Literature DB >> 11574372

Levobupivacaine combined with sufentanil and epinephrine for intrathecal labor analgesia: a comparison with racemic bupivacaine.

M P Vercauteren1, G Hans, K De Decker, H A Adriaensen.   

Abstract

UNLABELLED: We performed a randomized, double-blinded study to compare levobupivacaine with racemic bupivacaine for labor analgesia. Eighty term parturients received either levobupivacaine 0.125% or racemic bupivacaine 0.125%, to which was added sufentanil 0.75 microg/mL and epinephrine 1.25 microg/mL. As part of a combined spinal-epidural procedure, 2 mL of this mixture was initially injected intrathecally, and the same solutions were subsequently administered epidurally. For both combinations, onset until the first painless contraction was 4 to 5 min. Most patients were pain free during the second contraction. The duration of initial spinal analgesia was 93.5 +/- 20 min and 94.7 +/- 31 min for levobupivacaine and racemic bupivacaine, respectively. The duration of analgesia for the first epidural top-up dose was also similar in the two groups. Total local anesthetic requirements during labor were not different. The only major difference observed was the absence of motor impairment in levobupivacaine-treated parturients as compared with the Racemic Bupivacaine group, in which the incidence of a Bromage-1 motor block was 34%. Other side effects and obstetric or neonatal outcomes were not different between groups. Intrathecal levobupivacaine has a similar clinical profile as racemic bupivacaine, but at equal doses it produced less motor block. IMPLICATIONS: When used intrathecally and epidurally for labor analgesia, levobupivacaine had the same clinical profile as racemic bupivacaine, but at equal doses it produced less motor block.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574372     DOI: 10.1097/00000539-200110000-00040

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

Review 1.  Intrathecal opioids for combined spinal-epidural analgesia during labour.

Authors:  Peter DeBalli; Terrance W Breen
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Epidural analgesia for childbirth: effects of newer techniques on neonatal outcome.

Authors:  Giorgio Capogna; Michela Camorcia
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 3.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

4.  Intrathecal low-dose levobupivacaine and bupivacaine combined with fentanyl in a randomised controlled study for caesarean section: blockade characteristics, maternal and neonatal effects.

Authors:  K Misirlioglu; Gu Sivrikaya; A Hanci; A Yalcinkaya
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

Review 5.  Levobupivacaine: a review of its use in regional anaesthesia and pain management.

Authors:  Mark Sanford; Gillian M Keating
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

6.  Effects of levobupivacaine and bupivacaine on rat myometrium.

Authors:  Zi-gang Li; Liang Zhou; Hui-fang Tang
Journal:  J Zhejiang Univ Sci B       Date:  2006-09       Impact factor: 3.066

7.  A comparison of spinal anesthesia characteristics following intrathecal bupivacaine or levobupivacaine in lumbar disc surgery.

Authors:  Ayça Sultan Şahin; Gürkan Türker; Ahmet Bekar; Hülya Bilgin; Gülsen Korfalı
Journal:  Eur Spine J       Date:  2013-11-09       Impact factor: 3.134

8.  Progress in analgesia for labor: focus on neuraxial blocks.

Authors:  J Sudharma Ranasinghe; David J Birnbach
Journal:  Int J Womens Health       Date:  2010-08-09

Review 9.  [Levobupivacaine in obstetric analgesia and anaesthesia. Where is its place?].

Authors:  D H Bremerich; B Zwissler
Journal:  Anaesthesist       Date:  2004-07       Impact factor: 1.041

Review 10.  Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine.

Authors:  Chantal A A Heppolette; Derek Brunnen; Sohail Bampoe; Peter M Odor
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.